Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer

Published:2017-05 Issue:7652 Volume:545 Page:116-116
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Lu Xin,Horner James W.,Paul Erin,Shang Xiaoying,Troncoso Patricia,Deng Pingna,Jiang Shan,Chang Qing,Spring Denise J.,Sharma Padmanee,Zebala John A.,Maeda Dean Y.,Wang Y. Alan,DePinho Ronald A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22348.pdf

Reference1 articles.

1. Effective combinatorial immunotherapy for castration-resistant prostate cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy;Journal of Cancer Metastasis and Treatment;2024-03-25

2. The Role of Traditional Chinese Medicine in Cancer Immunotherapy: Current Status and Future Directions;The American Journal of Chinese Medicine;2023-01

3. Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines;International Journal of Molecular Sciences;2022-02-28

4. Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning;Oncotarget;2022-01-27

5. A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy;Cancer Immunology, Immunotherapy;2021-05-02